These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16354605)

  • 1. Symptoms and signs of an acute myocardial ischemia caused by chemotherapy with Paclitaxel (Taxol) in a patient with metastatic ovarian carcinoma.
    Schrader C; Keussen C; Bewig B; von Freier A; Lins M
    Eur J Med Res; 2005 Nov; 10(11):498-501. PubMed ID: 16354605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefit of electrocardiography during front-line combination paclitaxel and carboplatin chemotherapy for epithelial ovarian cancer.
    Kietpeerakool C; Tiyayon J; Suprasert P; Kanjanavanit R; Srisomboon J
    J Med Assoc Thai; 2006 Nov; 89(11):1805-10. PubMed ID: 17205858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute myocardial infarction and cardiac arrest in a patient receiving paclitaxel.
    Nguyen-Ho P; Kleiman NS; Verani MS
    Can J Cardiol; 2003 Mar; 19(3):300-2. PubMed ID: 12677287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase III trial of observation versus six courses of paclitaxel in patients with advanced epithelial ovarian cancer in complete response after six courses of paclitaxel/platinum-based chemotherapy: final results of the After-6 protocol 1.
    Pecorelli S; Favalli G; Gadducci A; Katsaros D; Panici PB; Carpi A; Scambia G; Ballardini M; Nanni O; Conte P;
    J Clin Oncol; 2009 Oct; 27(28):4642-8. PubMed ID: 19704064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute non-ST elevation myocardial infarction following paclitaxel administration for ovarian carcinoma: a case report and review of literature.
    Shah K; Gupta S; Ghosh J; Bajpai J; Maheshwari A
    J Cancer Res Ther; 2012; 8(3):442-4. PubMed ID: 23174732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group comparing quality of life in patients with ovarian cancer treated with cisplatin/paclitaxel versus carboplatin/paclitaxel.
    Greimel ER; Bjelic-Radisic V; Pfisterer J; Hilpert F; Daghofer F; du Bois A;
    J Clin Oncol; 2006 Feb; 24(4):579-86. PubMed ID: 16446330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel-induced ST-segment elevations.
    Gemici G; Cinçin A; Değertekin M; Oktay A
    Clin Cardiol; 2009 Jun; 32(6):E94-6. PubMed ID: 19382279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pegylated liposomal doxorubicin consolidation therapy after platinum/paclitaxel-based chemotherapy for suboptimally debulked, advanced-stage epithelial ovarian cancer patients.
    Rocconi RP; Straughn JM; Leath CA; Kilgore LC; Huh WK; Barnes MN; Partridge EE; Alvarez RD
    Oncologist; 2006 Apr; 11(4):336-41. PubMed ID: 16614229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reinduction of paclitaxel therapy after a successfully treated hypersensitivity reaction].
    Lehoczky O; Bagaméri A; Pulay T
    Orv Hetil; 2002 Sep; 143(38):2189-91. PubMed ID: 12395475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A reassessment of cardiac toxicity associated with Taxol.
    Arbuck SG; Strauss H; Rowinsky E; Christian M; Suffness M; Adams J; Oakes M; McGuire W; Reed E; Gibbs H
    J Natl Cancer Inst Monogr; 1993; (15):117-30. PubMed ID: 7912518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pemetrexed combined with paclitaxel in patients with advanced or metastatic non-small-cell lung cancer: a phase I-II trial.
    Stathopoulos GP; Dimitroulis J; Toubis M; Katis C; Karaindros D; Stathopoulos J; Koutandos J
    Lung Cancer; 2007 Jul; 57(1):66-71. PubMed ID: 17382431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abraxane in the treatment of ovarian cancer: the absence of hypersensitivity reactions.
    Micha JP; Goldstein BH; Birk CL; Rettenmaier MA; Brown JV
    Gynecol Oncol; 2006 Feb; 100(2):437-8. PubMed ID: 16226797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
    Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I trial of intraperitoneal sustained-release paclitaxel microspheres (Paclimer) in recurrent ovarian cancer: a Gynecologic Oncology Group study.
    Armstrong DK; Fleming GF; Markman M; Bailey HH
    Gynecol Oncol; 2006 Nov; 103(2):391-6. PubMed ID: 16626792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy-related acute myeloid leukemia with 11q23 abnormality due to paclitaxel coexisting with bone marrow metastasis of breast cancer].
    Saito M; Mori A; Irie T; Tanaka M; Morioka M
    Rinsho Ketsueki; 2009 Mar; 50(3):192-6. PubMed ID: 19352087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma.
    Safra T; Menczer J; Bernstein RM; Shpigel S; Matcejevsky D; Inbar MJ; Golan A; Grisaru D; Levy T
    Gynecol Oncol; 2009 Aug; 114(2):215-8. PubMed ID: 19446318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-eluting stent implantation in ST-elevation acute myocardial infarction: 'real world' 30-day and mid-term results.
    Novaro GM; Cherla A; Fromkin KR; Bush HS
    Cardiovasc Revasc Med; 2007; 8(1):5-8. PubMed ID: 17293262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taxol hypersensitivity: rapid retreatment is safe and cost effective.
    Olson JK; Sood AK; Sorosky JI; Anderson B; Buller RE
    Gynecol Oncol; 1998 Jan; 68(1):25-8. PubMed ID: 9454655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of an intraperitoneal chemotherapy program implemented at the Princess Margaret Hospital for patients with epithelial ovarian carcinoma.
    Chin SN; Pinto V; Rosen B; Oza A; Dodge J; Murphy J; Mackay H
    Gynecol Oncol; 2009 Mar; 112(3):450-4. PubMed ID: 19135709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.